Clinical Trial Update: Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating lenvatinib in combination with nivolumab and chemotherapy for metastatic gastric cancer with malignant ascites, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Neoplasms

Drugs mentioned

• LENVIMA (lenvatinib)
• OPDIVO (nivolumab)

Snippet

Sponsor: Asan Medical Center | Conditions: STOMACH NEOPLASM, Gastric Cancer | Phase 1, Phase 2 | Status: RECRUITING